What's new

Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 14, Status: Authorised

Mar 3, 2025 - 13:53
 0
Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 14, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Humira, adalimumab, Da...

Next Article

EY to develop CPK train business plan

Related Posts

List of signals discussed at PRAC since September 2012

Feb 10, 2025  0

Contact details of national competent authorities for r...

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0